US FDA accepts application for psoriasis drug: Sun Pharma
Drug major Sun Pharmaceutical Industries on Wednesday said the US health regulator has accepted biologics licence application (BLA) for tildrakizumab for the treatment of psoriasis.
May 24, 2017, 11:49 AM IST
Ranbaxy integration: Sun may drop some non-strategic units
Sun Pharma may discontinue certain non-strategic businesses as part of its integration process with Ranbaxy Laboratories, which it acquired in a USD 4 billion deal last year.
Nov 01, 2015, 10:58 AM IST
Sun Pharma shares crash 15%; m-cap dips by Rs 34,055 crore
Shares of Sun Pharma plunged 15 percent Tuesday, wiping out Rs 34,055.55 crore from its market valuation, after the drug major said it expects to take a hit on profit for the fiscal due to charges related to the ongoing integration with Ranbaxy Laboratories.
Jul 21, 2015, 19:10 PM IST
Sun Pharma, Ranbaxy rise after regulatory nods for merger deal
At the end of today's trade, Sun Pharmaceutical Industries ended at Rs 1,039.85, up 1.55 percent and Ranbaxy Laboratories closed at Rs 819.55 apiece, up 1.86 percent.
Mar 24, 2015, 17:33 PM IST
